Journal of the American Chemical Society
COMMUNICATION
A by exchanging the β6Àβ7 loop with that of sortase B, which
recognizes a different sorting motif, resulted in mutants that
possessed poor activity and hydrolyzed their substrates.11 Further-
more, the engineered F40-sortase was able to catalyze traceless
ligations of histone H3. This gain of function represents a very
useful feature for chromatin biochemistry, enabling simple access
to semisynthetic histones with defined modification patterns. In a
very recent publication, it was further shown that sortase A can be
evolved for improved catalytic activity.12 Together these inves-
tigations demonstrate amenability of sortase A to engineering
approaches, inspiring future manipulation experiments focused
on the substrate selectivity and catalytic properties of this class of
enzymes.
Figure 4. Semisynthesis of histone H3. (a) Scheme of histone H3
semisynthesis catalyzed by the F40-sortase. The native sequence of H3 is
restored at the ligation site (marked in red). (b) Fl-conjugated peptides
containing either the LPxTG or the native H3 APATG sequence were
ligated to recombinant histone H3 (33À135). The unligated H3
(33À135), 1, and the ligation products, 2, were separated on SDS-
PAGE and analyzed by Coomassie Brilliant Blue staining (bottom
panel) and UV irradiation (top panel). L = LPxTG peptide (Fl-Ahx-
LPKTGGRR-NH2); A = APxTG peptide (Fl-Ahx-SAPATGGK-NH2).
’ ASSOCIATED CONTENT
S
Supporting Information. Experimental procedures for
b
solid-phase peptide synthesis, construction and expression of
sortase constructs, phage-display, library design, ligation assays,
and additional experimental data. This material is available free of
amino acid sequence of the β6Àβ7 loop and not the loss of Ca2+
binding causes the promiscuity of the F40 mutant.
We next analyzed the human proteome for traceless ligation
sites of the F40-sortase mutant. The most interesting sequence
was the SAPATGG site in histone H3 covering residues 28À34.
Histones package DNA into chromatin and regulate gene activity
through a multitude of posttranslational modifications on their
N-terminal tail regions.9 Several ligation approaches have already
been tried in order to introduce site-specific modifications into
the tail region of histones for biological investigations.10 The
F40-sortase mutant appeared ideally suited for such an under-
taking because the APATG motif is located at the interface
between the tail and the globular domain of H3, and the Ala
residue in position 1 of the sorting motif is preferred by the F40
mutant. We subcloned and expressed a truncated version of
X. laevis H3 covering residues 33À135. Two Fl-conjugated peptides
containing either the sorting motif (Fl-Ahx-LPKTGGRR-NH2)
or the native 28À34 sequence of histone H3 (Fl-Ahx-SA-
PATGGK-NH2) were studied in ligation assays (Figure 4a).
Wt-sortase efficiently ligated the LPxTG but not the APxTG
peptide to H3 (33À135). In contrast, F40-sortase catalyzed the
ligation of the LPxTG only with marginal ligation efficiency, but
was able to ligate the APxTG to H3 (33À135), and thereby
restored the native amino acid sequence of H3 at the ligation site
(Figure 4b). Encouraged by these findings, we performed a
semisynthesis reaction to generate full-length histone H3. A
peptide covering residues 1À33 of histone H3 was synthesized
and subsequently ligated to H3 (33À135) by the F40-sortase.
Western blot analysis of the ligation reaction confirmed that F40-
sortase catalyzed the semisynthesis of full-length histone H3
(Figure S9).
In summary, we have reported the evolution of sortase A
mutants with modified substrate selectivities. Not surprisingly,
the F40-sortase mutant lost activity compared to the wt enzyme,
since our screen did not select for enhanced ligation efficiency.
However, the good solubility and stability of the engineered
sortase allowed for efficient ligation within 24 h of reaction time.
Therefore, the F40-sortase mutant can be used as a versatile tool
for in vitro applications for which low enzymatic efficacy is not
limiting. To the best of our knowledge, this investigation repre-
sents the first example of an engineered sortase A that maintained
ligation activity when the substrate recognition site was manipu-
lated. Earlier attempts to alter the substrate recognition of sortase
’ AUTHOR INFORMATION
Corresponding Author
beyerman@fmp-berlin.de; freund@fmp-berlin.de; schwarzer@
fmp-berlin.de
’ ACKNOWLEDGMENT
This work was supported by the Deutsche Forschungsge-
meinschaft to D.S. (SCHW 1163/3-1) and C.F. (SFB958,
project A07). We thank Rebecca Klingberg, Till Teschke, and
Bernhard Schmikale for support with solid-phase peptide synthesis.
’ REFERENCES
(1) (a) Hackenberger, C. P. R.; Schwarzer, D. Angew. Chem., Int. Ed.
2008, 47, 10030–10074. (b) Kent, S. B. H. Chem. Soc. Rev. 2009,
38, 338–351. (c) Muralidharan, V.; Muir, T. W. Nat. Methods 2006,
3, 429–438. (d) Sletten, E. M.; Bertozzi, C. R. Angew. Chem., Int. Ed.
2009, 48, 6974–6998.
(2) (a) Clancy, K. W.; Melvin, J. A.; McCafferty, D. G. Biopolymers
2010, 94, 385–396. (b) Popp, M. W.; Antos, J. M.; Grotenbreg, G. M.;
Spooner, E.; Ploegh, H. L. Nat. Chem. Biol. 2007, 3, 707–708. (c) Popp,
M. W.; Ploegh, H. L. Angew. Chem., Int. Ed. 2011, 50, 5024–5032.
(d) Pritz, S.; Kraetke, O.; Klose, A.; Klose, J.; Rothemund, S.; Fechner, K.;
Bienert, M.; Beyermann, M. Angew. Chem., Int. Ed. 2008, 47, 3642–3645.
(e) Tsukiji, S.; Nagamune, T. Chembiochem 2009, 10, 787–798.
(3) (a) Ton-That, H.; Marraffini, L. A.; Schneewind, O. Biochim.
Biophys. Acta 2004, 1694, 269–278. (b) Ton-That, H.; Mazmanian,
S. K.; Alksne, L.; Schneewind, O. J. Biol. Chem. 2002, 277, 7447–7452.
(4) (a) Kruger, R. G.; Otvos, B.; Frankel, B. A.; Bentley, M.; Dostal,
P.; McCafferty, D. G. Biochemistry 2004, 43, 1541–1551. (b) Mao, H. Y.;
Hart, S. A.; Schink, A.; Pollok, B. A. J. Am. Chem. Soc. 2004, 126, 2670–
2671.
(5) Atwell, S.; Wells, J. A. Proc. Natl. Acad. Sci. U.S.A. 1999, 96,
9497–9502.
(6) Zong, Y.; Bice, T. W.; Ton-That, H.; Schneewind, O.; Narayana,
S. V. J. Biol. Chem. 2004, 279, 31383–31389.
(7) Bentley, M. L.; Lamb, E. C.; McCafferty, D. G. J. Biol. Chem.
2008, 283, 14762–14771.
(8) (a) Ilangovan, U.; Iwahara, J.; Ton-That, H.; Schneewind, O.;
Clubb, R. T. J. Biomol. NMR 2001, 19, 379–380. (b) Ilangovan, U.;
17538
dx.doi.org/10.1021/ja205630g |J. Am. Chem. Soc. 2011, 133, 17536–17539